Yestar Healthcare Holdings Co. Ltd. announced that on 21 October 2025, its indirect wholly-owned subsidiary, Yestar Advanced Materials (HK) Co., Limited, entered into agreements for the acquisition of equipment related to the production of advanced materials. The acquisitions include production and testing equipment such as a membrane coating production line system, evaluation system, product packaging system, plasma treatment system, and other associated accessories and consumables. These transactions, when aggregated, constitute discloseable transactions under the Hong Kong Listing Rules, as the highest applicable percentage ratio exceeds 5% but is less than 25%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yestar Healthcare Holdings Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260206-12017830), on February 06, 2026, and is solely responsible for the information contained therein.